Search

everythinglearnresearchcommunity

for

Search:↓

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Hair transplant destroyed by lichen planopilaris.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

AR gene not major factor in female hair loss; different from male hair loss.